Ohba Y, Mochizuki N, Yamashita S, Chan AM, Schrader JW, Hattori S, et al
The adjustments are small: a to-go box, a protein and fiber anchor on the plate, and a post-meal walk around the block
Mild redness may occur temporarily at the injection site but this resolves quickly
Revised: May 2025 PRINCIPAL DISPLAY PANEL - 3 mL Pen Carton NDC 0024-5761-05 Rx only SOLIQUA 100/33 (insulin glargine and lixisenatide) injection For Single Patient Use Only 100 units/mL and 33 mcg/mL With each unit of insulin glargine, the pen also delivers 0.33 mcg of lixisenatide Only for Doses from 15 to 60 Units For subcutaneous injection only Dispense with the medication guide Solution for injection in a SoloStar disposable insulin delivery device Never remove medication using a syringe Do not mix with other insulins Use only if solution is clear and colorless with no particles visible Five 3 mL prefilled pens (15 mL total) Dispense in this sealed carton *Needles not included (see back panel) sanofi Biological Products Related to Soliqua Find detailed information on biosimilars for this medication
These challenges make it difficult, if not impossible, for patients to access the treatments they need to maintain their health and avoid more serious health complications
Most clinics recommend avoiding alcohol the night before and on the day of the procedure, since it increases bleeding risk and interacts with sedation or pain medications